BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34097488)

  • 1. Toward New Transmission-Blocking Combination Therapies: Pharmacokinetics of 10-Amino-Artemisinins and 11-Aza-Artemisinin and Comparison with Dihydroartemisinin and Artemether.
    Watson DJ; Laing L; Gibhard L; Wong HN; Haynes RK; Wiesner L
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0099021. PubMed ID: 34097488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Artemiside-Artemisox-Artemisone-M1 Tetrad: Efficacies against Blood Stage
    Gibhard L; Coertzen D; Reader J; van der Watt ME; Birkholtz LM; Wong HN; Batty KT; Haynes RK; Wiesner L
    Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal 10-Aminoartemisinins With Potent Transmission-Blocking Capabilities for New Artemisinin Combination Therapies-Activities Against Blood Stage
    Wong HN; Padín-Irizarry V; van der Watt ME; Reader J; Liebenberg W; Wiesner L; Smith P; Eribez K; Winzeler EA; Kyle DE; Birkholtz LM; Coertzen D; Haynes RK
    Front Chem; 2019; 7():901. PubMed ID: 31998692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacies and ADME properties of redox active methylene blue and phenoxazine analogues for use in new antimalarial triple drug combinations with amino-artemisinins.
    Watson DJ; Laing L; Petzer JP; Wong HN; Parkinson CJ; Wiesner L; Haynes RK
    Front Pharmacol; 2023; 14():1308400. PubMed ID: 38259296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of in vitro/in vivo blood distribution and pharmacokinetics of artemisinin, artemether and dihydroartemisinin in rats.
    Dai T; Jiang W; Guo Z; Xie Y; Dai R
    J Pharm Biomed Anal; 2019 Jan; 162():140-148. PubMed ID: 30240987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics and bioavailability of dihydroartemisinin, arteether, artemether, artesunic acid and artelinic acid in rats.
    Li QG; Peggins JO; Fleckenstein LL; Masonic K; Heiffer MH; Brewer TG
    J Pharm Pharmacol; 1998 Feb; 50(2):173-82. PubMed ID: 9530985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and bioavailability of oral and intramuscular artemether.
    Karbwang J; Na-Bangchang K; Congpuong K; Molunto P; Thanavibul A
    Eur J Clin Pharmacol; 1997; 52(4):307-10. PubMed ID: 9248770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative bioavailability of oral, rectal, and intramuscular artemether in healthy subjects: use of simultaneous measurement by high performance liquid chromatography and bioassay.
    Teja-Isavadharm P; Nosten F; Kyle DE; Luxemburger C; Ter Kuile F; Peggins JO; Brewer TG; White NJ
    Br J Clin Pharmacol; 1996 Nov; 42(5):599-604. PubMed ID: 8951191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption of the novel artemisinin derivatives artemisone and artemiside: potential application of Pheroid™ technology.
    Steyn JD; Wiesner L; du Plessis LH; Grobler AF; Smith PJ; Chan WC; Haynes RK; Kotzé AF
    Int J Pharm; 2011 Jul; 414(1-2):260-6. PubMed ID: 21596127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The multiple-dosing pharmacokinetics of artemether, artesunate, and their metabolite dihydroartemisinin in rats.
    Xing J; Bai KH; Liu T; Wang RL; Zhang LF; Zhang SQ
    Xenobiotica; 2011 Mar; 41(3):252-8. PubMed ID: 21175296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing antimalarial drug resistance with triple artemisinin-based combination therapies.
    Nguyen TD; Gao B; Amaratunga C; Dhorda M; Tran TN; White NJ; Dondorp AM; Boni MF; Aguas R
    Nat Commun; 2023 Jul; 14(1):4568. PubMed ID: 37516752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From artemisinin to new artemisinin antimalarials: biosynthesis, extraction, old and new derivatives, stereochemistry and medicinal chemistry requirements.
    Haynes RK
    Curr Top Med Chem; 2006; 6(5):509-37. PubMed ID: 16719805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malaria and artemisinin derivatives: an updated review.
    Ansari MT; Saify ZS; Sultana N; Ahmad I; Saeed-Ul-Hassan S; Tariq I; Khanum M
    Mini Rev Med Chem; 2013 Nov; 13(13):1879-902. PubMed ID: 24070206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration.
    Morris CA; Duparc S; Borghini-Fuhrer I; Jung D; Shin CS; Fleckenstein L
    Malar J; 2011 Sep; 10():263. PubMed ID: 21914160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of UGTs polymorphism on the auto-induction phase II metabolism-mediated pharmacokinetics of dihydroartemisinin in healthy Chinese subjects after oral administration of a fixed combination of dihydroartemisinin-piperaquine.
    Zang M; Zhu F; Zhao L; Yang A; Li X; Liu H; Xing J
    Malar J; 2014 Dec; 13():478. PubMed ID: 25476790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo activity of endoperoxide antimalarials, including artemisone and arterolane, against multidrug-resistant Plasmodium falciparum isolates from Cambodia.
    Lanteri CA; Chaorattanakawee S; Lon C; Saunders DL; Rutvisuttinunt W; Yingyuen K; Bathurst I; Ding XC; Tyner SD
    Antimicrob Agents Chemother; 2014 Oct; 58(10):5831-40. PubMed ID: 25049252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of artemether and dihydroartemisinin following single intramuscular dosing of artemether in African children with severe falciparum malaria.
    Mithwani S; Aarons L; Kokwaro GO; Majid O; Muchohi S; Edwards G; Mohamed S; Marsh K; Watkins W
    Br J Clin Pharmacol; 2004 Feb; 57(2):146-52. PubMed ID: 14748813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gametocyte Clearance Kinetics Determined by Quantitative Magnetic Fractionation in Melanesian Children with Uncomplicated Malaria Treated with Artemisinin Combination Therapy.
    Karl S; Laman M; Moore BR; Benjamin J; Koleala T; Ibam C; Kasian B; Siba PM; Waltmann A; Mueller I; Woodward RC; St Pierre TG; Davis TM
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4489-96. PubMed ID: 25987625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.